BioLife Solutions Executes 10 Year Supply Agreement with Kite Pharma for CryoStor® Use in CAR T Cell Therapies
![T-cell graphic](https://www.biolifesolutions.com/wp-content/uploads/2023/01/Cryopreservation-cell.jpg)
BioLife and Kite Pharma are pleased to announce that they have entered into a 10 year supply agreement for BioLife’s CryoStor clinical grade freeze media for cells and tissues, which is embedded in Kite’s manufacturing process for KTE-C19, a CAR T cell therapy. Kite Pharma is currently in four clinical trials for various cancers. Marc […]